Whittier Trust Co. of Nevada Inc. Sells 31,380 Shares of Elevance Health, Inc. $ELV

Whittier Trust Co. of Nevada Inc. lessened its position in Elevance Health, Inc. (NYSE:ELV) by 80.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,740 shares of the company’s stock after selling 31,380 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Elevance Health were worth $2,713,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Nilsine Partners LLC boosted its stake in Elevance Health by 1.5% during the 3rd quarter. Nilsine Partners LLC now owns 1,918 shares of the company’s stock valued at $620,000 after purchasing an additional 29 shares during the last quarter. HBK Sorce Advisory LLC raised its position in Elevance Health by 4.4% in the 3rd quarter. HBK Sorce Advisory LLC now owns 743 shares of the company’s stock worth $260,000 after buying an additional 31 shares during the last quarter. Detalus Advisors LLC lifted its stake in Elevance Health by 1.8% during the 3rd quarter. Detalus Advisors LLC now owns 1,726 shares of the company’s stock valued at $558,000 after acquiring an additional 31 shares during the period. Forum Financial Management LP boosted its holdings in shares of Elevance Health by 1.1% during the 3rd quarter. Forum Financial Management LP now owns 2,971 shares of the company’s stock valued at $960,000 after acquiring an additional 33 shares during the last quarter. Finally, Vermillion & White Wealth Management Group LLC grew its stake in shares of Elevance Health by 94.9% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock worth $30,000 after acquiring an additional 37 shares during the period. Institutional investors own 89.24% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ELV. Barclays increased their price target on Elevance Health from $385.00 to $404.00 and gave the company an “overweight” rating in a report on Monday, January 5th. Wolfe Research set a $425.00 target price on Elevance Health and gave the company an “outperform” rating in a report on Thursday, January 8th. Bank of America boosted their price target on Elevance Health from $330.00 to $370.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. Truist Financial set a $400.00 price objective on shares of Elevance Health in a research note on Tuesday, October 14th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Elevance Health from $384.00 to $394.00 and gave the stock an “overweight” rating in a report on Tuesday, October 28th. Twelve research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $399.63.

Elevance Health Stock Performance

Shares of NYSE ELV opened at $370.77 on Monday. The stock has a market cap of $82.40 billion, a PE ratio of 15.16, a price-to-earnings-growth ratio of 1.91 and a beta of 0.51. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $458.75. The firm has a fifty day moving average price of $349.17 and a 200-day moving average price of $328.67. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.56 and a quick ratio of 1.56.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.